International Guideline Harmonization Group
Home
About IGHG
Members
Core group
Guideline panels
Breast cancer
Cardiomyopathy
Premature ovarian insufficiency
Male gonadotoxicity
Thyroid cancer
Ototoxicty
Obstetric care
Central nervous system neoplasms
Fatigue, mental health and psychosocial problems
Fertility preservation
Hypothalamic-pituitary dysfunction
Coronary artery disease
Metabolic syndrome
Pulmonary dysfunction
Bone mineral density
Hepatic toxicity
Nephrotoxicity
Neurocognitive problems
Colorectal cancer
Splenic dysfunction
Dexrazoxane cardioprotection
Growth hormone treatment
COVID-19 Statement
Thyroid dysfunction
Collaborators
Funding sources
Methods
Process
Grading system
Topic selection
Publication
Handbook
Guidelines
Topics
Breast cancer
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Cardiomyopathy
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Premature ovarian insufficiency
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Male gonadotoxicity
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Thyroid cancer
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Ototoxicity
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Obstetric care
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Central nervous system neoplasms
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Fatigue
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Psychosocial problems
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Mental health problems
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Coronary artery disease
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Fertility preservation
Recommendations
Conclusions of evidence
Evidence tables
Publications
Guideline panel
Bone mineral density
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Hepatic toxicity
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Hypothalamic-pituitary dysfunction
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Metabolic syndrome
Guideline panel
Nephrotoxicity
Guideline panel
Colorectal cancer
Guideline panel
Neurocognitive problems
Guideline panel
Pulmonary dysfunction
Guideline panel
Splenic dysfunction
Guideline panel
Dexrazoxane cardioprotection
Recommendations
Conclusions of evidence
Evidence tables
Publication
Guideline panel
Growth hormone treatment
Thyroid dysfunction
Guideline panel
COVID-19 Statement
Patient education
News
Meetings
Contact
Dexrazoxane cardioprotection
Home
Guidelines
Topics
Dexrazoxane cardioprotection
Conclusions of evidence
Conclusions of evidence